Jean-Yves Pierga - JoVE Visualize

Showing results (11-20 of 244) with videos related to

Pageof 25

Sort By:

Journal of Breast Cancer|May 13, 2020

ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast CancerMarcela Carausu, Samia Melaabi, Jean-Yves Pierga, et al.

American Journal of Clinical Oncology|July 16, 2025

Concurrent Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: Assessing the EfficacyJihane Bouziane, Pierre Loap, Sofiane Allali, et al.

NPJ Breast Cancer|November 29, 2024

Circulating tumor cells in breast cancer: clinical validity and utilityThibault Thomas-Bonafos, Jean Yves Pierga, François-Clément Bidard, et al.

Bulletin Du Cancer|November 7, 2024

[Triple negative breast cancer: Current status and perspectives]Fanny Le Du, Emilie Moati, Pauline Vaflard, et al.

Bulletin Du Cancer|July 30, 2004

[Update on docetaxel and breast cancer]Véronique Diéras, Véronique Girre, Jean-Yves Pierga, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2016

Rate of Distant Metastases on 18F-FDG PET/CT at Initial Staging of Breast Cancer: Comparison of Women Younger and Older Than 40 YearsVincent Lebon, Jean-Louis Alberini, Jean-Yves Pierga, et al.

Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 1, 2022

Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancerPierre Loap, Benjamin Nicaise, Fatima Laki, et al.

Bulletin Du Cancer|February 7, 2004

[Targeting epidermal growth factor receptor in cancer of the breast]Véronique Diéras, Jean-Yves Pierga, Anne Vincent-Salomon, et al.

Cancers|January 11, 2022

Radiotherapy in the Management of Non-Metastatic Inflammatory Breast Cancers: A Retrospective Observational StudyBenjamin Nicaise, Pierre Loap, Delphine Loirat, et al.

NPJ Breast Cancer|June 29, 2018

Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancerMarie-Laure Tanguy, Luc Cabel, Fréderique Berger, et al.

Pageof 25

Showing results (11-20 of 244) with videos related to

Sort By:

Pageof 25

Journal of Breast Cancer|May 13, 2020

ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast CancerMarcela Carausu, Samia Melaabi, Jean-Yves Pierga, et al.

American Journal of Clinical Oncology|July 16, 2025

Concurrent Trastuzumab Deruxtecan and Radiation Therapy in HER2-positive and HER2-low Metastatic Breast Cancer: Assessing the EfficacyJihane Bouziane, Pierre Loap, Sofiane Allali, et al.

NPJ Breast Cancer|November 29, 2024

Circulating tumor cells in breast cancer: clinical validity and utilityThibault Thomas-Bonafos, Jean Yves Pierga, François-Clément Bidard, et al.

Bulletin Du Cancer|November 7, 2024

[Triple negative breast cancer: Current status and perspectives]Fanny Le Du, Emilie Moati, Pauline Vaflard, et al.

Bulletin Du Cancer|July 30, 2004

[Update on docetaxel and breast cancer]Véronique Diéras, Véronique Girre, Jean-Yves Pierga, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2016

Rate of Distant Metastases on 18F-FDG PET/CT at Initial Staging of Breast Cancer: Comparison of Women Younger and Older Than 40 YearsVincent Lebon, Jean-Louis Alberini, Jean-Yves Pierga, et al.

Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 1, 2022

Clinical outcomes of curative-intent multimodal management of chemorefractory nonmetastatic inflammatory breast cancerPierre Loap, Benjamin Nicaise, Fatima Laki, et al.

Bulletin Du Cancer|February 7, 2004

[Targeting epidermal growth factor receptor in cancer of the breast]Véronique Diéras, Jean-Yves Pierga, Anne Vincent-Salomon, et al.

Cancers|January 11, 2022

Radiotherapy in the Management of Non-Metastatic Inflammatory Breast Cancers: A Retrospective Observational StudyBenjamin Nicaise, Pierre Loap, Delphine Loirat, et al.

NPJ Breast Cancer|June 29, 2018

Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancerMarie-Laure Tanguy, Luc Cabel, Fréderique Berger, et al.

Pageof 25